Possibilities and Predictions...., page-35

In regard to Merck and Immutep......

Currently Immutep is financing all combos with Mercks keytruda.......

In Australia because of Australia's generous PBS scheme our

combo trials are exclusively funded by Immutep and I might

add Immutep instigated......

Our combo trials with keytruda in the USA are financed by

Immutep with Mercks committments simply the supply of

keytruda.....So essentially we are paying ......It is not apparent

who or how these combos come to fruition, I suspect it was

an approach to Merck on the back of our Aussie melanoma trial

early indications...So,if I'm correct, Immutep is still doing the

hard yards to get  "efti" recognised as an  aid to keytruda's 

further and improved success....

We've done our bit, it's time for Merck to come to the party

if they wish to try our "efti"in further collaborations.....

I'm sure Marc Voight would be pursuing this objective

in no uncertain terms.....